Cargando…
Contributions of molecular biology to antipsychotic drug discovery: promises fulfilled or unfulfilled?
This review summarizes the various conceptual paradigms for treating schizophrenia, and indicates how molecular biology and drug discovery technologies can accelerate the development of new medications. As yet, there is no convincing data that a crucial druggable molecular target exists which, if ta...
Autor principal: | Roth, Bryan L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Les Laboratoires Servier
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181824/ https://www.ncbi.nlm.nih.gov/pubmed/17117612 |
Ejemplares similares
-
Pharmacogenetics and outcome with antipsychotic drugs
por: Pouget, Jennie G., et al.
Publicado: (2014) -
Treatment mechanisms: traditional and new antipsychotic drugs
por: Tamminga, Carol A.
Publicado: (2000) -
New directions for drug discovery
por: Spedding, Michael
Publicado: (2006) -
Pharmacogenetics of antipsychotic-induced side effects
por: Lencz, Todd, et al.
Publicado: (2009) -
Inhibition of the reward system by antipsychotic treatment
por: Juckel, Georg
Publicado: (2016)